AzTrials
AzTrials

Suicidal IdeationNCT04781166

An Online Intervention to Reduce Self-Harm Among Persons With High Emotion-Related Impulsivity

A study testing Calm program in people with Suicidal Ideation and Deliberate Self-harm, run by University of California, Berkeley at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The goal of this program is to test a brief, online, cognitive behavioral intervention for people who struggle with self-harm or suicidal urges or behavior in the context of emotion-related impulsivity. Read more about this study

Who is it for?
Ages 13 years and older
What is being tested?
Calm program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
1 siteUnited States
Study dates
15 Apr 2021to 1 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • at least 13 years of age
  • engaged in mental health care
  • evidence of either self-harm or suicidal urges or behavior in the past 3 months
  • high levels of emotion-related impulsivity.

Who cannot join

  • inability to adequately take part in the online measures due to problems with intellectual function, language, or other conditions,
  • psychosis,
  • not currently living in California,
  • lack of access to a device to privately complete online modules.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of California

    Berkeley, California, 94720

Other trials in United States

About this study

Official title: An Online Intervention to Reduce Self-Harm Among Persons With High Emotion-Related

The goal of this program is to test a brief, online, cognitive behavioral intervention for people who struggle with self-harm or suicidal urges or behavior in the context of emotion-related impulsivity.

Read the detailed description

Participants will be asked to complete 7 brief online modules to cover how to understand emotion-triggered impulsivity, to better detect states of high emotion and arousal, to learn new strategies for self-calming high arousal, and to pre-plan how to cope with high arousal states. As part of the program, participants receive daily texts and prompts to remind them of the intervention content and skills. At baseline and follow-up, participants will complete measures of emotion-related impulsivity, self-harm, and suicidality.

Being tested
Calm program
Medical subject headings
Suicidal Ideation, Self-Injurious Behavior, Impulsive Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Calm programBehavioural

    7 online modules designed to teach cognitive behavioral skills

Study groups in NCT04781166
Study groupRoleWhat they receive
InterventionExperimentalParticipants will be immediately assigned to the intervention.
Receives: Behavioral: Calm program
Waitlist controlOtherParticipants will complete measures before and after a waitlist equivalent to the duration of the intervention, to assess whether change is observed with time and repeated assessment. After the waitlist control, participants will be provided the opportunity to take part in the intervention. In this RDICT design, the pre- post- treatment data will be included in analyses.
Receives: Behavioral: Calm program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in suicidal ideation among adults

    Columbia Suicide Severity Rating scale suicidal ideation severity score; scores range from 0 to 5, where 5 is more severe.

    Measured: immediately before the intervention and one week after intervention

  2. Change in interview-rated suicidal ideation among adolescent patients

    Self-Injurious Thoughts and Behaviors Interview suicidal ideation in the past month scored as the sum of the items on the worst intensity, average intensity, and likelihood of suicidal ideation items; scores range from 0 to 12, with higher scores reflecting greater severity.

    Measured: immediately before the intervention and one week after intervention

  3. Change in self-rated suicidal ideation among adolescent patients

    Suicide Ideation Questionnaire Jr; scores range from 0 to 6, where 6 is more severe

    Measured: immediately before the intervention and one week after intervention

  4. Change in self-rated deliberate self-harm

    Deliberate Self-Harm Inventory Frequency in past month score, from 0 to number of incidents reported (higher scores are worse outcomes)

    Measured: immediately before the intervention and one week after intervention

  5. Change in interview-based self-harm among adolescent patients

    Self-Injurious Thoughts and Behaviors Interview NSSI severity in the past month, scored as the sum of the items on the worst intensity, average intensity, and likelihood of NSSI items; scores range from 0 to 12 with higher scores reflecting greater severity.

    Measured: immediately before the intervention and one week after intervention

  6. Change in impulsivity

    self-rated Three factor impulsivity Feelings Trigger Action subscale; scores range from 1 to 5, where 5 reflects more severe impulsivity

    Measured: immediately before the intervention and one week after intervention

  7. Change in interview-based impulsivity among adolescent patients

    Urgency interview scores, scored as the sum of 8 items, range = 0 to 16, where higher scores reflect more impulsivity.

    Measured: immediately before the intervention and one week after intervention

Secondary outcomes (1)
  1. Change in aggression

    Bryant Aggression scale: mean of physical aggression, verbal aggression, and anger subscales; range of scores from 1 to 5, where 5 = more severe aggression

    Measured: immediately before the intervention and one week after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2021
  2. Study start15 Apr 2021
  3. Primary completion1 Oct 2021
  4. Study completion1 Oct 2021

Why it stopped: Lack of recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Adult participants will be enrolled in the intervention, and we will use pre-, post-data to evaluate whether the program appears to be helpful. Adolescent participants will be randomly assigned to a waitlist control or intervention; those in the waitlist will be offered the intervention after they complete the waitlist period.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04781166
Sponsor's protocol ID
UC CPHS 2016-01-8287
Status last verified
Nov 2023
First submitted
19 Feb 2021
Last updated
18 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will provide fully de-identified data on OSF.

Questions about this trial

What is this clinical trial studying?

A study testing Calm program in people with Suicidal Ideation and Deliberate Self-harm, run by University of California, Berkeley at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Lack of recruitment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in suicidal ideation among adults (time frame: immediately before the intervention and one week after intervention). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in